Epigral Ltd

NSE: EPIGRAL · BSE: 543332 · Chemicals & Petrochemicals · 31 announcements

Share price: ₹1,019.90
Market cap: ₹4,400 Cr
Revenue (annual): ₹2,527 Cr
Net profit (annual): ₹332.0 Cr
P/E (TTM): 16.2×Sector 37.2×
Promoter holding: 68.83%+0.00% QoQ
FII holding: 1.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Financial Results 4 Annual General Meeting 4 Board Meeting Date 3 Results Update 2 Other Announcement 2 Dividend 2 Credit Rating 2 Capacity Expansion 2 Price Movement Clarification 1 Merger & Restructuring 1 Management Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Jul 2026 14:12 IST BSE

Results Update

Epigral Results Update

Epigral reported Q1FY27 PAT of ₹99 Crore, a 25% YoY increase. The company plans ₹600 Crore capex for Epoxy Resin and Multi-Purpose Plant.

Value: ₹600.0 Cr
Execution: H2FY28

Read the filing ↗

2 May 2026 16:10 IST BSE

Results Update

Epigral Results Update

Epigral Ltd reported record Q4FY26 revenue of ₹736 Crore, up 17% year-on-year, driven by volume growth and improved realizations. The Board proposed a final dividend of ₹5 per share. While PAT stood at ₹82 Crore, EBITDA margins improved to 23%. The company continues its strategic capex expansions in CPVC and Epichlorohydrin capacities.

Value: ₹736.0 Cr

Read the filing ↗